Our leadership

We are uniquely positioned to develop and potentially commercialize imetelstat, with significant regulatory experience in hematologic malignancies and the manufacturing of oligonucleotides.

Management

John A. Scarlett, M.D.

Chairman of the Board, President and Chief Executive Officer
Olivia K. Bloom

Executive Vice President, Finance, Chief Financial Officer and Treasurer
Melissa A. Kelly Behrs

Executive Vice President, Business Operations and Chief Alliance Officer
Faye Feller, M.D.

Executive Vice President, Chief Medical Officer
Andrew J. Grethlein, Ph.D.

Executive Vice President, Chief Operating Officer
Anil Kapur

Executive Vice President, Corporate Strategy and Chief Commercial Officer
Edward Koval

Executive Vice President and Chief Business Officer
Stephen N. Rosenfield, J.D.

Executive Vice President, Chief Legal Officer and Corporate Secretary

Board of Directors

John A. Scarlett, M.D.

Chairman of the Board, President and Chief Executive Officer
Dawn C. Bir

Nominating and Corporate Governance Committee
Karin Eastham

Lead Independent Director, Audit Committee and Compensation Committee
V. Bryan Lawlis, Ph.D.

Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee
John F. McDonald

Audit Committee
Susan M. Molineaux, Ph.D.

Nominating and Corporate Governance Committee (Chair)
Elizabeth G. O’Farrell

Audit Committee (Chair)
Robert J. Spiegel, M.D., FACP

Compensation Committee (Chair)
Culture

We see things in ways others
do not